Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-07-06

FDA Approved: TRI-MILI — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approves TRI-MILI (norgestimate and ethinyl estradiol) for contraception under Original Application by Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRI-MILI (Norgestimate and Ethinyl Estradiol)

Snippet

ORIG AP for TRI-MILI (NORGESTIMATE AND ETHINYL ESTRADIOL)